_id
69130e56ccc777a4e85d7db3
Ticker
LGVN
Name
Longeveron LLC
Exchange
NASDAQ
Address
Life Science & Technology Park, Miami, FL, United States, 33136
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://longeveron.com
Description
Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States. Its lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and healthy adult donors which is in phase 1 clinical trial to treat hypoplastic left heart syndrome; completed phase 2a clinical trial to treat Alzheimer's disease, as well as in phase 2b clinical trial to treat aging frailty. The company was incorporated in 2014 and is headquartered in Miami, Florida.
Last Close
0.5062
Volume
513627
Current Price
0.6233
Change
0.087
Last Updated
2026-01-04T16:30:11.377Z
Image
data:image/webp;base64,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
Ipo Date
2021-02-12T00:00:00.000Z
Market Cap
14715423
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.997
Sentiment Sources
1
Rating
4
Target Price
6.8625
Strong Buy
0
Buy
3
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
137000
Cost Of Revenue
12000
Gross Profit
125000
Operating Expenses
7435000
Operating Income
-7310000
Interest Expense
-
Pretax Income
-7221000
Net Income
-7221000
Eps
-0.39301813434982846
Dividends Per Share
-
Shares Outstanding
19848876
Income Tax Expense
-
EBITDA
-6957000
Operating Margin
-5335.766423357664
Total Other Income Expense Net
89000
Cash
9244000
Short Term Investments
-
Receivables
52000
Inventories
-
Total Current Assets
10340000
Property Plant Equipment
2730000
Total Assets
15557000
Payables
1080000
Short Term Debt
647000
Long Term Debt
-
Total Liabilities
5591000
Equity
9966000
Bs_currency_symbol
USD
Depreciation
264000
Change In Working Capital
1074000
Cash From Operations
-5055000
Capital Expenditures
57000
Cash From Investing
-118000
Cash From Financing
4083000
Net Change In Cash
-1090000
Cf_currency_symbol
USD
PE
-
PB
1.149108399899659
ROE
-72.45635159542444
ROA
-46.4164041910394
FCF
-5112000
Fcf Percent
-37.31386861313869
Piotroski FScore
1
Health Score
31
Deep Value Investing Score
5
Defensive Investing Score
6.5
Dividend Investing Score
1.5
Economic Moat Investing Score
4.3
Garp Investing Score
2
Growth Investing Score
1
Momentum Investing Score
6.5
Net Net Investing Score
3.5
Quality Investing Score
2
Value Investing Score
4
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
137000
Quarters > 0 > income Statement > cost Of Revenue
12000
Quarters > 0 > income Statement > gross Profit
125000
Quarters > 0 > income Statement > operating Expenses
7435000
Quarters > 0 > income Statement > operating Income
-7310000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-7221000
Quarters > 0 > income Statement > net Income
-7221000
Quarters > 0 > income Statement > eps
-0.39301813434982846
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
18373198
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-6957000
Quarters > 0 > income Statement > operating Margin
-5335.766423357664
Quarters > 0 > income Statement > total Other Income Expense Net
89000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
9244000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
52000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
10340000
Quarters > 0 > balance Sheet > property Plant Equipment
2730000
Quarters > 0 > balance Sheet > total Assets
15557000
Quarters > 0 > balance Sheet > payables
1080000
Quarters > 0 > balance Sheet > short Term Debt
647000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
5591000
Quarters > 0 > balance Sheet > equity
9966000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-7221000
Quarters > 0 > cash Flow > depreciation
264000
Quarters > 0 > cash Flow > change In Working Capital
1074000
Quarters > 0 > cash Flow > cash From Operations
-5055000
Quarters > 0 > cash Flow > capital Expenditures
57000
Quarters > 0 > cash Flow > cash From Investing
-118000
Quarters > 0 > cash Flow > cash From Financing
4083000
Quarters > 0 > cash Flow > net Change In Cash
-1090000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.39301813434982846
Quarters > 0 > ratios > PB
1.149108399899659
Quarters > 0 > ratios > ROE
-72.45635159542444
Quarters > 0 > ratios > ROA
-46.4164041910394
Quarters > 0 > ratios > FCF
-5112000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-37.31386861313869
Quarters > 0 > health Score
31
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
316000
Quarters > 1 > income Statement > cost Of Revenue
170000
Quarters > 1 > income Statement > gross Profit
146000
Quarters > 1 > income Statement > operating Expenses
5543000
Quarters > 1 > income Statement > operating Income
-5397000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-5028000
Quarters > 1 > income Statement > net Income
-5028000
Quarters > 1 > income Statement > eps
-0.3349081387207095
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
15013072
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-4765000
Quarters > 1 > income Statement > operating Margin
-1707.9113924050635
Quarters > 1 > income Statement > total Other Income Expense Net
369000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
10334000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
31000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
11269000
Quarters > 1 > balance Sheet > property Plant Equipment
2959000
Quarters > 1 > balance Sheet > total Assets
16749000
Quarters > 1 > balance Sheet > payables
700000
Quarters > 1 > balance Sheet > short Term Debt
639000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
4093000
Quarters > 1 > balance Sheet > equity
12656000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-5028000
Quarters > 1 > cash Flow > depreciation
263000
Quarters > 1 > cash Flow > change In Working Capital
655000
Quarters > 1 > cash Flow > cash From Operations
-3597000
Quarters > 1 > cash Flow > capital Expenditures
161000
Quarters > 1 > cash Flow > cash From Investing
-263000
Quarters > 1 > cash Flow > cash From Financing
-133000
Quarters > 1 > cash Flow > net Change In Cash
-3993000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.3349081387207095
Quarters > 1 > ratios > PB
0.739384306068268
Quarters > 1 > ratios > ROE
-39.72819216182048
Quarters > 1 > ratios > ROA
-30.019702668816052
Quarters > 1 > ratios > FCF
-3758000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-11.89240506329114
Quarters > 1 > health Score
34
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
381000
Quarters > 2 > income Statement > cost Of Revenue
106000
Quarters > 2 > income Statement > gross Profit
275000
Quarters > 2 > income Statement > operating Expenses
5456000
Quarters > 2 > income Statement > operating Income
-5181000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-5011000
Quarters > 2 > income Statement > net Income
-5011000
Quarters > 2 > income Statement > eps
-0.3351674907733627
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
14950734
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-4760000
Quarters > 2 > income Statement > operating Margin
-1359.8425196850394
Quarters > 2 > income Statement > total Other Income Expense Net
170000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
14327000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
29000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
15275000
Quarters > 2 > balance Sheet > property Plant Equipment
3081000
Quarters > 2 > balance Sheet > total Assets
20848000
Quarters > 2 > balance Sheet > payables
367000
Quarters > 2 > balance Sheet > short Term Debt
631000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
3690000
Quarters > 2 > balance Sheet > equity
17158000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-5011000
Quarters > 2 > cash Flow > depreciation
421000
Quarters > 2 > cash Flow > change In Working Capital
-447000
Quarters > 2 > cash Flow > cash From Operations
-4697000
Quarters > 2 > cash Flow > capital Expenditures
27000
Quarters > 2 > cash Flow > cash From Investing
-150000
Quarters > 2 > cash Flow > cash From Financing
-58000
Quarters > 2 > cash Flow > net Change In Cash
-4905000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.3351674907733627
Quarters > 2 > ratios > PB
0.5431164764075067
Quarters > 2 > ratios > ROE
-29.205035551929132
Quarters > 2 > ratios > ROA
-24.03587874136608
Quarters > 2 > ratios > FCF
-4724000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-12.398950131233596
Quarters > 2 > health Score
34
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
603000
Quarters > 3 > income Statement > cost Of Revenue
73000
Quarters > 3 > income Statement > gross Profit
530000
Quarters > 3 > income Statement > operating Expenses
4811000
Quarters > 3 > income Statement > operating Income
-4281000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-4081000
Quarters > 3 > income Statement > net Income
-4081000
Quarters > 3 > income Statement > eps
-0.274076561450638
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
14890000
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-4039000
Quarters > 3 > income Statement > operating Margin
-709.9502487562189
Quarters > 3 > income Statement > total Other Income Expense Net
200000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
19232000
Quarters > 3 > balance Sheet > short Term Investments
0
Quarters > 3 > balance Sheet > receivables
84000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
19624000
Quarters > 3 > balance Sheet > property Plant Equipment
3331000
Quarters > 3 > balance Sheet > total Assets
25558000
Quarters > 3 > balance Sheet > payables
99000
Quarters > 3 > balance Sheet > short Term Debt
623000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
3671000
Quarters > 3 > balance Sheet > equity
21887000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-4081000
Quarters > 3 > cash Flow > depreciation
242000
Quarters > 3 > cash Flow > change In Working Capital
943000
Quarters > 3 > cash Flow > cash From Operations
-3373000
Quarters > 3 > cash Flow > capital Expenditures
13000
Quarters > 3 > cash Flow > cash From Investing
-123000
Quarters > 3 > cash Flow > cash From Financing
-50000
Quarters > 3 > cash Flow > net Change In Cash
-3546000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.274076561450638
Quarters > 3 > ratios > PB
0.4240387901494037
Quarters > 3 > ratios > ROE
-18.64577146251199
Quarters > 3 > ratios > ROA
-15.967603098834024
Quarters > 3 > ratios > FCF
-3386000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-5.615257048092869
Quarters > 3 > health Score
34
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
2392000
Annuals > 0 > income Statement > cost Of Revenue
508000
Annuals > 0 > income Statement > gross Profit
1884000
Annuals > 0 > income Statement > operating Expenses
18406000
Annuals > 0 > income Statement > operating Income
-16522000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-15973000
Annuals > 0 > income Statement > net Income
-15973000
Annuals > 0 > income Statement > eps
-1.0727333781061115
Annuals > 0 > income Statement > dividends Per Share
8650000
Annuals > 0 > income Statement > shares Outstanding
14890000
Annuals > 0 > income Statement > income Tax Expense
-24623000
Annuals > 0 > income Statement > EBITDA
-15564000
Annuals > 0 > income Statement > operating Margin
-690.7190635451504
Annuals > 0 > income Statement > total Other Income Expense Net
549000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
19232000
Annuals > 0 > balance Sheet > short Term Investments
0
Annuals > 0 > balance Sheet > receivables
84000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
19624000
Annuals > 0 > balance Sheet > property Plant Equipment
3331000
Annuals > 0 > balance Sheet > total Assets
25558000
Annuals > 0 > balance Sheet > payables
99000
Annuals > 0 > balance Sheet > short Term Debt
623000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
3671000
Annuals > 0 > balance Sheet > equity
21887000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-15973000
Annuals > 0 > cash Flow > depreciation
958000
Annuals > 0 > cash Flow > change In Working Capital
-1241000
Annuals > 0 > cash Flow > cash From Operations
-13868000
Annuals > 0 > cash Flow > capital Expenditures
992000
Annuals > 0 > cash Flow > cash From Investing
-640000
Annuals > 0 > cash Flow > cash From Financing
28791000
Annuals > 0 > cash Flow > net Change In Cash
14283000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-1.0727333781061115
Annuals > 0 > ratios > PB
0.4034253209667839
Annuals > 0 > ratios > ROE
-72.97939416091744
Annuals > 0 > ratios > ROA
-62.49706549808279
Annuals > 0 > ratios > FCF
-14860000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-6.212374581939799
Annuals > 0 > health Score
33
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
709000
Annuals > 1 > income Statement > cost Of Revenue
488000
Annuals > 1 > income Statement > gross Profit
221000
Annuals > 1 > income Statement > operating Expenses
21250000
Annuals > 1 > income Statement > operating Income
-21029000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-21413000
Annuals > 1 > income Statement > net Income
-21413000
Annuals > 1 > income Statement > eps
-9.85189717919107
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
2173490
Annuals > 1 > income Statement > income Tax Expense
778105
Annuals > 1 > income Statement > EBITDA
-20083000
Annuals > 1 > income Statement > operating Margin
-2966.0084626234134
Annuals > 1 > income Statement > total Other Income Expense Net
-384000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
4949000
Annuals > 1 > balance Sheet > short Term Investments
412000
Annuals > 1 > balance Sheet > receivables
111000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
5848000
Annuals > 1 > balance Sheet > property Plant Equipment
3750000
Annuals > 1 > balance Sheet > total Assets
12078000
Annuals > 1 > balance Sheet > payables
638000
Annuals > 1 > balance Sheet > short Term Debt
593000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
5337000
Annuals > 1 > balance Sheet > equity
6741000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-21413000
Annuals > 1 > cash Flow > depreciation
946000
Annuals > 1 > cash Flow > change In Working Capital
36000
Annuals > 1 > cash Flow > cash From Operations
-19002000
Annuals > 1 > cash Flow > capital Expenditures
301000
Annuals > 1 > cash Flow > cash From Investing
8186000
Annuals > 1 > cash Flow > cash From Financing
5262000
Annuals > 1 > cash Flow > net Change In Cash
-5554000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-9.85189717919107
Annuals > 1 > ratios > PB
0.1912000548879988
Annuals > 1 > ratios > ROE
-317.65316718587746
Annuals > 1 > ratios > ROA
-177.28928630567975
Annuals > 1 > ratios > FCF
-19303000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-27.225669957686883
Annuals > 1 > health Score
29
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
1222000
Annuals > 2 > income Statement > cost Of Revenue
725000
Annuals > 2 > income Statement > gross Profit
497000
Annuals > 2 > income Statement > operating Expenses
18540000
Annuals > 2 > income Statement > operating Income
-18043000
Annuals > 2 > income Statement > interest Expense
287000
Annuals > 2 > income Statement > pretax Income
-18835000
Annuals > 2 > income Statement > net Income
-18835000
Annuals > 2 > income Statement > eps
-8.98229436459388
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
2096903
Annuals > 2 > income Statement > income Tax Expense
792000
Annuals > 2 > income Statement > EBITDA
-17150000
Annuals > 2 > income Statement > operating Margin
-1476.5139116202945
Annuals > 2 > income Statement > total Other Income Expense Net
-792000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
10503000
Annuals > 2 > balance Sheet > short Term Investments
9155000
Annuals > 2 > balance Sheet > receivables
218000
Annuals > 2 > balance Sheet > inventories
-622000
Annuals > 2 > balance Sheet > total Current Assets
20280000
Annuals > 2 > balance Sheet > property Plant Equipment
4480000
Annuals > 2 > balance Sheet > total Assets
27413000
Annuals > 2 > balance Sheet > payables
1751000
Annuals > 2 > balance Sheet > short Term Debt
564000
Annuals > 2 > balance Sheet > long Term Debt
2041000
Annuals > 2 > balance Sheet > total Liabilities
6910000
Annuals > 2 > balance Sheet > equity
20503000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-18835000
Annuals > 2 > cash Flow > depreciation
893000
Annuals > 2 > cash Flow > change In Working Capital
238000
Annuals > 2 > cash Flow > cash From Operations
-13969000
Annuals > 2 > cash Flow > capital Expenditures
856000
Annuals > 2 > cash Flow > cash From Investing
-677000
Annuals > 2 > cash Flow > cash From Financing
-509000
Annuals > 2 > cash Flow > net Change In Cash
-15155000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-8.98229436459388
Annuals > 2 > ratios > PB
0.06064787977369165
Annuals > 2 > ratios > ROE
-91.86460517972979
Annuals > 2 > ratios > ROA
-68.70827709480903
Annuals > 2 > ratios > FCF
-14825000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-12.131751227495908
Annuals > 2 > health Score
33
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
1306000
Annuals > 3 > income Statement > cost Of Revenue
716000
Annuals > 3 > income Statement > gross Profit
590000
Annuals > 3 > income Statement > operating Expenses
18046000
Annuals > 3 > income Statement > operating Income
-17456000
Annuals > 3 > income Statement > interest Expense
4000
Annuals > 3 > income Statement > pretax Income
-17045000
Annuals > 3 > income Statement > net Income
-17045000
Annuals > 3 > income Statement > eps
-9.011328527291452
Annuals > 3 > income Statement > dividends Per Share
451000
Annuals > 3 > income Statement > shares Outstanding
1891508
Annuals > 3 > income Statement > income Tax Expense
-58000
Annuals > 3 > income Statement > EBITDA
-16127000
Annuals > 3 > income Statement > operating Margin
-1336.6003062787136
Annuals > 3 > income Statement > total Other Income Expense Net
411000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
25658000
Annuals > 3 > balance Sheet > short Term Investments
9385000
Annuals > 3 > balance Sheet > receivables
55000
Annuals > 3 > balance Sheet > inventories
281718
Annuals > 3 > balance Sheet > total Current Assets
35380000
Annuals > 3 > balance Sheet > property Plant Equipment
4875000
Annuals > 3 > balance Sheet > total Assets
42766000
Annuals > 3 > balance Sheet > payables
645000
Annuals > 3 > balance Sheet > short Term Debt
537000
Annuals > 3 > balance Sheet > long Term Debt
2605000
Annuals > 3 > balance Sheet > total Liabilities
5313000
Annuals > 3 > balance Sheet > equity
37453000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-17045000
Annuals > 3 > cash Flow > depreciation
914000
Annuals > 3 > cash Flow > change In Working Capital
-1090000
Annuals > 3 > cash Flow > cash From Operations
-9636000
Annuals > 3 > cash Flow > capital Expenditures
1310000
Annuals > 3 > cash Flow > cash From Investing
-10696000
Annuals > 3 > cash Flow > cash From Financing
45174000
Annuals > 3 > cash Flow > net Change In Cash
24842000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-9.011328527291452
Annuals > 3 > ratios > PB
0.02994858206285211
Annuals > 3 > ratios > ROE
-45.510373000827705
Annuals > 3 > ratios > ROA
-39.85642800355422
Annuals > 3 > ratios > FCF
-10946000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-8.381316998468606
Annuals > 3 > health Score
34
Valuation > metrics > PE
-0.39301813434982846
Valuation > metrics > PB
1.149108399899659
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-72.45635159542444
Profitability > metrics > ROA
-69.83558994197293
Profitability > metrics > Net Margin
-52.70802919708029
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.5610074252458358
Risk > metrics > Interest Coverage
-27.689393939393938
Risk > final Score
-63
Risk > verdict
High
Liquidity > metrics > Current Ratio
5.987261146496815
Liquidity > metrics > Quick Ratio
5.987261146496815
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-22
Prev Risks > 1
-23
Prev Risks > 2
-348
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:08:13.800Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-12
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.39
Earnings History > 0 > eps Estimate
-0.26
Earnings History > 0 > eps Difference
-0.13
Earnings History > 0 > surprise Percent
-50
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-13
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.33
Earnings History > 1 > eps Estimate
-0.35
Earnings History > 1 > eps Difference
0.02
Earnings History > 1 > surprise Percent
5.7143
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-08
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.34
Earnings History > 2 > eps Estimate
-0.33
Earnings History > 2 > eps Difference
-0.01
Earnings History > 2 > surprise Percent
-3.0303
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-02-28
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.27
Earnings History > 3 > eps Estimate
-0.2
Earnings History > 3 > eps Difference
-0.07
Earnings History > 3 > surprise Percent
-35
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-12
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.34
Earnings History > 4 > eps Estimate
-0.44
Earnings History > 4 > eps Difference
0.1
Earnings History > 4 > surprise Percent
22.7273
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-15
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-1.83
Earnings History > 5 > eps Estimate
-0.87
Earnings History > 5 > eps Difference
-0.96
Earnings History > 5 > surprise Percent
-110.3448
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-14
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-1.61
Earnings History > 6 > eps Estimate
-2
Earnings History > 6 > eps Difference
0.39
Earnings History > 6 > surprise Percent
19.5
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-02-27
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.25
Earnings History > 7 > eps Estimate
-0.21
Earnings History > 7 > eps Difference
-0.04
Earnings History > 7 > surprise Percent
-19.0476
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-09
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.28
Earnings History > 8 > eps Estimate
-0.22
Earnings History > 8 > eps Difference
-0.06
Earnings History > 8 > surprise Percent
-27.2727
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-11
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.27
Earnings History > 9 > eps Estimate
-0.25
Earnings History > 9 > eps Difference
-0.02
Earnings History > 9 > surprise Percent
-8
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-12
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.22
Earnings History > 10 > eps Estimate
-0.21
Earnings History > 10 > eps Difference
-0.01
Earnings History > 10 > surprise Percent
-4.7619
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-10
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.21
Earnings History > 11 > eps Estimate
-0.17
Earnings History > 11 > eps Difference
-0.04
Earnings History > 11 > surprise Percent
-23.5294
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-14
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.25
Earnings History > 12 > eps Estimate
-0.21
Earnings History > 12 > eps Difference
-0.04
Earnings History > 12 > surprise Percent
-19.0476
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-12
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.27
Earnings History > 13 > eps Estimate
-0.23
Earnings History > 13 > eps Difference
-0.04
Earnings History > 13 > surprise Percent
-17.3913
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-13
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.17
Earnings History > 14 > eps Estimate
-0.22
Earnings History > 14 > eps Difference
0.05
Earnings History > 14 > surprise Percent
22.7273
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-11
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.2
Earnings History > 15 > eps Estimate
-0.25
Earnings History > 15 > eps Difference
0.05
Earnings History > 15 > surprise Percent
20
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-12-22
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.25
Earnings History > 16 > eps Estimate
-
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-13
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.26
Earnings History > 17 > eps Estimate
-
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-14
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.18
Earnings History > 18 > eps Estimate
-
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-30
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.07
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
-0.07
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-12-31
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.6574
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
-0.6574
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-09-30
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.0585
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
-0.0585
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-06-30
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.0761
Earnings History > 22 > eps Estimate
0
Earnings History > 22 > eps Difference
-0.0761
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2019-09-30
Earnings History > 23 > report Date
2019-12-31
Earnings History > 23 > date
2019-09-30
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.2318
Earnings History > 23 > eps Estimate
0
Earnings History > 23 > eps Difference
-0.2318
Earnings History > 23 > surprise Percent
-
Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States. Its lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and healthy adult donors which is in phase 1 clinical trial to treat hypoplastic left heart syndrome; completed phase 2a clinical trial to treat Alzheimer's disease, as well as in phase 2b clinical trial to treat aging frailty. The company was incorporated in 2014 and is headquartered in Miami, Florida.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/APortfolio Recap: Can LGVN deliver alpha - Weekly Trade Analysis & Smart Investment Allocation Insights baoquankhu1.vn
Read more →Aug Action: Can LGVN continue delivering strong returns - Weekly Risk Summary & Advanced Technical Signal Analysis baoquankhu1.vn
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$6.8625
Analyst Picks
Strong Buy
0
Buy
3
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 4.61% of the total shares of Longeveron LLC
1.
Vanguard Group Inc(0.6937%)
since
2025/06/30
2.
Geode Capital Management, LLC(0.6804%)
since
2025/06/30
3.
Vanguard Institutional Extnd Mkt Idx Tr(0.4766%)
since
2025/07/31
4.
Citadel Advisors Llc(0.4503%)
since
2025/06/30
5.
UBS Group AG(0.4046%)
since
2025/06/30
6.
Fidelity Extended Market Index(0.3492%)
since
2025/07/31
7.
XTX Topco Ltd(0.2308%)
since
2025/06/30
8.
State Street Corp(0.2182%)
since
2025/06/30
9.
Capital Investment Advisory Services, LLC(0.1275%)
since
2025/06/30
10.
Commonwealth Equity Services Inc(0.121%)
since
2025/06/30
11.
Fidelity Total Market Index(0.1157%)
since
2025/07/31
12.
Fidelity Series Total Market Index(0.0981%)
since
2025/07/31
13.
Northern Trust Corp(0.0764%)
since
2025/06/30
14.
NT Ext Equity Mkt Idx Fd - L(0.0732%)
since
2025/06/30
15.
Northern Trust Extended Eq Market Idx(0.0732%)
since
2025/06/30
16.
Spartan Extended Market Index Pool F(0.0686%)
since
2025/07/31
17.
Lido Advisors, LLC(0.054%)
since
2025/06/30
18.
BlackRock Inc(0.0482%)
since
2025/06/30
19.
Bank of Montreal(0.0481%)
since
2025/06/30
20.
BMO Capital Markets Corp.(0.0481%)
since
2025/06/30
21.
Spartan Total Market Index Pool G(0.0347%)
since
2025/07/31
22.
Tower Research Capital LLC(0.0247%)
since
2025/06/30
23.
NT Ext Eq Mkt Indx Fd DC Lending Tier 5(0.0207%)
since
2025/06/30
24.
NT Ext Eq Mkt Indx Fd DC Lend T3(0.0174%)
since
2024/12/31
25.
Fidelity Nasdaq Composite Index(0.0141%)
since
2025/07/31
26.
Steward Partners Investment Advisory, LLC(0.0114%)
since
2025/06/30
27.
Advisor Group Holdings, Inc.(0.0096%)
since
2025/06/30
28.
Extended Equity Market Fund K(0.007%)
since
2025/06/30
29.
Morgan Stanley - Brokerage Accounts(0.0033%)
since
2025/06/30
30.
NT Ext Equity Mkt Idx Fd - NL(0.0029%)
since
2025/06/30
31.
NT Ext Equity Mkt Idx Fd - DC - NL - T2(0.0023%)
since
2025/06/30
32.
Extended Equity Market Fund M(0.0009%)
since
2025/06/30
33.
Bank of America Corp(0.0006%)
since
2025/06/30
34.
Hanson Mcclain Inc(0.0006%)
since
2025/06/30
35.
State St US Extended Mkt Indx NL Cl C(0.0006%)
since
2025/08/31
36.
State St US Ttl Mkt Indx NL Cl A(0.0003%)
since
2025/08/31
37.
SBI Securities Co Ltd(0.0002%)
since
2025/06/30
38.
SSgA U.S. Total Market Index Strategy(0.0002%)
since
2025/03/31
39.
Northern Trust Wilshire 5000(0.0002%)
since
2025/06/30
40.
Fidelity U.S. Equity Index Ins Trust(0%)
since
2025/07/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.39
EPS Estimate
-0.26
EPS Difference
-0.13
Surprise Percent
-50%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.